113 related articles for article (PubMed ID: 3108420)
1. [Clinical evaluation of the prolactin secreting capacity for the diagnosis of occult hyperprolactinemia].
Matsuoka R; Mori H; Tomonari R; Chen SZ; Kigawa T; Aisaka K
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Apr; 39(4):586-90. PubMed ID: 3108420
[TBL] [Abstract][Full Text] [Related]
2. [Role of TRH or metoclopramide loading test in the diagnosis of so-called occult or latent hyperprolactinemia].
Aisaka K; Ando S; Kokuho K; Kaneda S; Tawada T; Yoshida K; Mori H
Nihon Naibunpi Gakkai Zasshi; 1987 Jul; 63(7):853-61. PubMed ID: 3119381
[TBL] [Abstract][Full Text] [Related]
3. [The effects of pregnancy on prolactin secretion in occulted hyperprolactinemia].
Matsuoka R; Mori H
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Dec; 43(12):1617-22. PubMed ID: 1744458
[TBL] [Abstract][Full Text] [Related]
4. [Effects of transient or occult hyperprolactinemia on luteal function].
Aisaka K; Ando S; Kokubo K; Yoshida K; Mori H
Nihon Naibunpi Gakkai Zasshi; 1986 Feb; 62(2):117-25. PubMed ID: 3084307
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of prolactin-secreting-capacity to circadian profile of prolactin in euprolactinemic women with ovulatory disturbances].
Mori H; Aisaka K; Matsuoka R; Kigawa T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Feb; 37(2):287-92. PubMed ID: 3919123
[TBL] [Abstract][Full Text] [Related]
6. [Galactorrhea].
Iino Y; Mori H
Nihon Rinsho; 1997 Nov; 55(11):2914-9. PubMed ID: 9396287
[TBL] [Abstract][Full Text] [Related]
7. Luteal phase hyperprolactinemia.
Falk RJ; Anderson L
Int J Fertil Menopausal Stud; 1994; 39(5):272-7. PubMed ID: 7820160
[TBL] [Abstract][Full Text] [Related]
8. Catecholamines and pituitary function. VI. Effect of different dopamine doses on TRH-induced prolactin release in women with pathological hyperprolactinemia.
Nicoletti I; Ambrosi F; Pagliacci MC; Pelicci G; Giammartino C; Maggio D; Fedeli L; Filipponi P
Horm Metab Res; 1987 Mar; 19(3):125-9. PubMed ID: 3106177
[TBL] [Abstract][Full Text] [Related]
9. Changes in the prolactin response to thyrotropin-releasing hormone (TRH) during the menstrual cycle of normal women.
Boyd AE; Sanchez-Franco F
J Clin Endocrinol Metab; 1977 May; 44(5):985-9. PubMed ID: 404311
[TBL] [Abstract][Full Text] [Related]
10. Occult hyperprolactinemia in infertile women.
Asukai K; Uemura T; Minaguchi H
Fertil Steril; 1993 Sep; 60(3):423-7. PubMed ID: 8375520
[TBL] [Abstract][Full Text] [Related]
11. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
[TBL] [Abstract][Full Text] [Related]
12. [A study with diagnostic standard of occult hyperprolactinemia (OHP) and the effect of bromocriptine administration].
Aisaka K; Kaneda S; Tsuzuki H; Toriya Y; Kokuho K; Tamechika S; Saitoh H; Yoshida K; Mori H
Nihon Naibunpi Gakkai Zasshi; 1993 Oct; 69(9):1017-27. PubMed ID: 8262272
[TBL] [Abstract][Full Text] [Related]
13. [Prolactin and TSH response in functional tests in patients with primary hypothyroidism in a context of hyperprolactinemia].
Chernova TO; Kolesnikova GS; Mudretsova SV; Serpukhovitin SIu; Goncharov NP; Gereasimov GA
Probl Endokrinol (Mosk); 1994; 40(5):16-8. PubMed ID: 7899431
[TBL] [Abstract][Full Text] [Related]
14. [The value of functional tests in diagnosis of prolactinoma].
Klockenbusch W; Distler W; von Ditfurth M; Graf M; Jahn K
Geburtshilfe Frauenheilkd; 1990 May; 50(5):383-7. PubMed ID: 2115483
[TBL] [Abstract][Full Text] [Related]
15. Prolactin and thyroid-stimulating hormone responses to thyrotropin-releasing hormone in cases of hyperprolactinemia with normal and abnormal sella tomograms.
Badawy SZ; Moses A; Streeten D; Marshall L; Marlin D; Notman D
Int J Fertil; 1983; 28(4):213-8. PubMed ID: 6142012
[TBL] [Abstract][Full Text] [Related]
16. Hyperprolactinemia: comparison of thyrotropic-releasing hormone and tomography.
Shangold GA; Kletzky OA; Marrs RP; Mishell DR
Obstet Gynecol; 1984 Jun; 63(6):771-5. PubMed ID: 6427715
[TBL] [Abstract][Full Text] [Related]
17. Catecholamines and pituitary function. III. Restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia.
Nicoletti I; Filipponi P; Fedeli L; Sfrappini M; Gregorini G; Ambrosi F; Santeusanio F
Horm Res; 1984; 20(3):202-12. PubMed ID: 6436160
[TBL] [Abstract][Full Text] [Related]
18. [The mechanism of induction of ovulation by bromocriptine in euprolactinemic anovulation--the role of occult hyperprolactinemia in anovulation].
Mori H; Aisaka K; Matsuoka R; Kigawa T
Nihon Naibunpi Gakkai Zasshi; 1985 Jan; 61(1):38-47. PubMed ID: 3996685
[TBL] [Abstract][Full Text] [Related]
19. [A study on pathogenesis and treatment of normoprolactinemic galactorrhea syndrome].
Aisaka K; Ando S; Kokubo K; Sasaki S; Sudo I; Toriya Y; Yoshida K; Mori H
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2385-92. PubMed ID: 4078422
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic sulpiride-induced hyperprolactinemia on menstrual cycles of normal women.
Oseko F; Morikawa K; Motohashi T; Aso T
Obstet Gynecol; 1988 Aug; 72(2):267-71. PubMed ID: 3134632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
